Výsledky vyhledávání - "John M. Turnbow"

A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings

Autor: Floyd R. Sallee, Mary Ann McDonnell, Andrea Marraffino, Norberto J. DeSousa, Bev Incledon, Sharon B. Wigal, Matthew Brams, John M. Turnbow, Ann C. Childress, Andrew J. Cutler

Publikováno v: Journal of Child and Adolescent Psychopharmacology

Objectives: HLD200, a once-daily, evening-dosed, delayed-release and extended-release methylphenidate (DR/ER-MPH), was designed to provide therapeutic effect beginning upon awakening and lasting into the evening. This pivotal, randomized, double-blin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1957af7b71e132269a47e8506436eec0
https://doi.org/10.1089/cap.2019.0070

Zobrazit plný text záznamu

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

Autor: John M. Turnbow, Ann C. Childress, Matthew Brams, Heidi W. Belden, Yulia Pincus, Sharon B. Wigal, Sally A. Berry

Publikováno v: Journal of Child and Adolescent Psychopharmacology

Objectives: To determine the efficacy and safety of amphetamine extended-release oral suspension (AMPH EROS) in the treatment of attention-deficit/hyperactivity disorder (ADHD) in a dose-optimized, randomized, double-blind, parallel-group study. Meth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba94d4c62dd97a1ac9f6ea225b11b15
https://doi.org/10.1089/cap.2017.0095

Zobrazit plný text záznamu

Morning and Evening Effects of Guanfacine Extended Release Adjunctive to Psychostimulants in Pediatric ADHD

Autor: Timothy E. Wilens, Carla White, John M. Turnbow, Sharon Youcha, Thomas Rugino, Keith McBurnett

Publikováno v: Journal of Attention Disorders. 21:110-119

Objective: To examine efficacy and safety of adjunctive guanfacine extended release (GXR) on morning and evening ADHD symptoms using the Conners’ Global Index–Parent (CGI-P) and Before-School Functioning Questionnaire (BSFQ). Method: Participants

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8748b801e8c0df56605776799190edb2
https://doi.org/10.1177/1087054713500144

Zobrazit plný text záznamu

The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study

Autor: Ann C. Childress, Scott H. Kollins, Andrew J. Cutler, Jo Northcutt, John M. Turnbow, Matthew Brams, Americo Padilla

Publikováno v: Journal of Child and Adolescent Psychopharmacology

Objective: The study goal was to determine the efficacy and safety of an optimal dose of Evekeo, racemic amphetamine sulfate, 1:1 d-amphetamine and l-amphetamine (R-AMPH), compared to placebo in treating children with attention-deficit/hyperactivity

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d495752a5e89dd2feebeed878ef1a6
https://doi.org/10.1089/cap.2014.0176

Zobrazit plný text záznamu

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials

Autor: Howard Abikoff, Rich Civil, Robert L. Findling, Samuel W. Boellner, John M. Turnbow, Sharon B. Wigal, Oscar G. Bukstein

Publikováno v: Clinical Therapeutics. 31:1844-1855

Background: Short-term treatment with the meth-ylphenidate transdermal system (MTS) has been well tolerated in several clinical trials in children with attention-deficit/hyperactivity disorder (ADHD). However, the effects of long-term use have not be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d416aadcbc4fabc194dc6f3fc55056b4
https://doi.org/10.1016/j.clinthera.2009.08.002

Zobrazit plný text záznamu

A Randomized, Double-Blind, Crossover Study of Once-Daily Dexmethylphenidate in Children with Attention-Deficit Hyperactivity Disorder

Autor: Kevin McCague, Matthew Brams, Rafael Muniz, Alice R. Mao, John Giblin, Raul R. Silva, Frank A. Lopez, Ann C. Childress, John M. Turnbow, Mary Borrello

Publikováno v: CNS Drugs. 22:693-704

Background: Long-acting methylphenidate formulations provide control of attention-deficit hyperactivity disorder (ADHD) symptoms for up to 12 hours; however, not all formulations have rapid onset of therapeutic effect, which is essential for providin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6714d008334757658b7210d85d936e
https://doi.org/10.2165/00023210-200822080-00006

Zobrazit plný text záznamu

A Randomized, Double-Blind, Placebo-Controlled, Laboratory Classroom Assessment of Methylphenidate Transdermal System in Children With ADHD

Autor: Eliot Moon, James J. McGough, John M. Turnbow, Howard Abikoff, Kelly Posner, Sharon B. Wigal

Publikováno v: Journal of Attention Disorders. 9:476-485

Objective: This study evaluates the efficacy, duration of action, and tolerability of methylphenidate transdermal system (MTS) in children with ADHD. Method: Participants were dose optimized over 5 weeks utilizing patch doses of 10, 16, 20, and 27 mg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::968cc225fdd8a6c3c44c717a25d71f39
https://doi.org/10.1177/1087054705284089

Zobrazit plný text záznamu

A randomized, double-blind study of 30 versus 20 mg dexmethylphenidate extended-release in children with attention-deficit/hyperactivity disorder: late-day symptom control

Autor: Ann C. Childress, John M. Turnbow, Linda Pestreich, Matthew Brams, Rafael Muniz, John Giblin, Kevin McCague

Publikováno v: Journal of clinical psychopharmacology. 32(5)

The objective of this study was to evaluate the safety and efficacy of dexmethylphenidate extended-release (d-MPH-ER) 30 versus 20 mg in children with attention-deficit/hyperactivity disorder (ADHD) in a 12-hour laboratory classroom setting. In a ran

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7145085a91b9aeb753aeb8b3b796e5b
https://pubmed.ncbi.nlm.nih.gov/22926597

Zobrazit plný text záznamu

Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder

Autor: Scott H. Kollins, Frank A. Lopez, Kimberly Farrand, Bradley D. Vince, Sharon B. Wigal, John M. Turnbow, Andrew Lyne, Thomas Roth

Publikováno v: Journal of child and adolescent psychopharmacology. 21(2)

To determine whether treatment with guanfacine extended release (GXR) in subjects with attention-deficit/hyperactivity disorder (ADHD) disrupted psychomotor functioning and alertness, or impacted daytime sleepiness.This was a randomized, double-blind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bb2a3211fe98ec6fb9971506f81fec1
https://pubmed.ncbi.nlm.nih.gov/21476931

Zobrazit plný text záznamu

A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents

Autor: Rich Civil, Robert L. Findling, Yunfeng Li, Raun D. Melmed, John Burnside, John M. Turnbow

Publikováno v: CNS spectrums. 15(7)

Introduction: The current report evaluates the efficacy and safety of methylphenidate transdermal system (MTS) compared with placebo transdermal system (PTS) in adolescents with attention-deficit/hyperactivity disorder (ADHD).Methods: A total of 217

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcc4cca5637800cc1c86c717a51b6ef2
https://pubmed.ncbi.nlm.nih.gov/20625364

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání